Inspiratory Muscle Training in ME/CFS and COVID-19 Survivors
Launched by YORK UNIVERSITY · Jan 17, 2022
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Approximately 10 women and 10 men between the ages of 18-65 will be tested in each of 3 groups:
1. Control participants will be free of previously diagnosed cardiovascular, metabolic, autonomic, or respiratory disease.
2. COVID-19 participants will have both an official diagnosis and an official clearance of COVID-19. Patients will have long-haul symptoms for at least 3 months. Patients will be recruited via media, social media and clinical collaborators.
3. ME/CFS participants will be recruited via media, social media and clinical collaborators. Only those with mild to moderate symptoms w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Control participants will be free of previously diagnosed cardiovascular, metabolic, autonomic, or respiratory disease.
- • COVID-19 participants will have both an official diagnosis and an official clearance of COVID-19. Patients will have long-haul symptoms for at least 3 months. Patients will be recruited via media, social media and clinical collaborators.
- • ME/CFS participants will be recruited via media, social media and clinical collaborators. Only those with mild to moderate symptoms who can complete a 6 minute walk test will be recruited.
- Exclusion Criteria:
- • severe symptoms of chronic fatigue syndrome
- • inability to stand on a tilt table
- • inability to walk for 6 minutes
- • previous cardiorespiratory disease (except for COVID long-hauler symptoms and chronic fatigue syndrome itself)
- • inability to understand and read English.
About York University
York University is a leading research institution located in Toronto, Canada, dedicated to advancing knowledge and fostering innovation across various disciplines. With a strong emphasis on interdisciplinary collaboration, York University actively engages in clinical trials aimed at improving health outcomes and addressing critical medical challenges. The university's commitment to ethical research practices, coupled with its state-of-the-art facilities and experienced faculty, positions it as a pivotal sponsor in the clinical research landscape, contributing valuable insights to the scientific community and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Heather Edgell, PhD
Principal Investigator
York University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials